Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome Mounjaro pens contain a small volume of extra medicine beyond the four standard weekly doses — often called a "bonus dose" or fifth dose. Whether that extra liquid can safely be used depends on the pen format, your injection technique, and your prescriber's guidance. It is a prescription-only medicine, so any decision about additional doses must be made with a clinician, not independently. Here is what the evidence and the licensed prescribing information actually say.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro KwikPen is a pre-filled, single-use device. Eli Lilly fills each pen with a defined total volume at each strength (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg) calculated to reliably deliver four complete weekly injections through the auto-injector mechanism. Manufacturing tolerances mean a small overfill is built in to guarantee each of the four labelled doses is full-strength. After the fourth injection, a detectable quantity of liquid often remains in the barrel.
That leftover volume is the origin of the "bonus dose" term. It has circulated in online forums and social media, with some users claiming they extracted a fifth injection. The volume present varies and is not calibrated to be a therapeutic dose. The pen itself locks after the fourth use and is designed to be discarded. More about how the four-dose pen is constructed explains the device mechanics clearly, including why the locking mechanism exists.
The key point at this stage: the existence of residual liquid does not mean a fifth dose is available, safe, or sanctioned. It means manufacturing engineering provides a buffer, for the device's benefit, not yours.
Before drawing any conclusion about residual volume, hold the pen up to natural light and look at the viewing window after the fourth dose. You will often see a small cloudy or clear remainder. A practical check you can do in under a minute: press the dose button gently after the fourth injection and watch whether the plunger moves at all, on a properly exhausted pen, it will not depress further. If it does move, the pen may not have delivered the fourth dose fully, which is a different problem from a bonus-dose situation and one to report to your pharmacy promptly.
Injection technique affects how much medicine actually enters your body. Removing the pen too quickly, injecting at the wrong angle, or not holding it in place for the full time stated in the Mounjaro Summary of Product Characteristics on the eMC can all result in under-delivery. If you are regularly noticing significant leftover liquid, that is worth raising with your prescriber, it may indicate a technique issue rather than a manufacturing quirk.
Dosing in millilitres is a separate but related question. Understanding Mounjaro doses in ml covers the volumes at each strength so you can follow prescribing information accurately.
The licensed position is straightforward. The Mounjaro pen is approved by the MHRA for four weekly doses per pen. There is no licensed fifth dose. The NHS tirzepatide page advises patients to follow the prescriber's instructions and the patient information leaflet precisely, and to use the pen only as directed. Extracting residual medicine with a separate needle or syringe is explicitly outside the intended use of the device, introduces contamination risk, and makes accurate dosing impossible because the residual volume is variable and unmetered.
This matters particularly at higher strengths. At 15 mg, the therapeutic dose is already the ceiling of the licensed schedule. An improvised extra dose at that strength would represent an unlicensed dose beyond the maximum, not a clinical grey area, but a clear risk. At lower doses, the concern is different: the residual volume may be too small to constitute a clinically meaningful injection even if it were safely extracted, which makes the effort pointless as well as unsafe.
If cost is part of why someone is considering stretching a pen further, understanding what private treatment genuinely costs (and what is included) is worth doing separately. Mounjaro cost in the UK covers the full picture honestly.
The practical question behind most bonus-dose searches is this: what do I do if I have run out of medicine and my next pen has not arrived? The answer from prescribing guidance is to contact your prescriber or dispensing pharmacy the same day. A missed dose within a few days of the scheduled injection window may be manageable; going beyond that window has implications for both tolerability and efficacy that a clinician needs to assess. Your prescriber can advise on timing based on your individual treatment history.
Supply concerns are best raised before you reach the final dose. At nume, our prescribers are available for aftercare seven days a week, so if stock or delivery timing is a worry, getting in touch with our team early gives the most options. Treatment at 5 mg or any other dose follows a supervised schedule; a prescriber's guidance on a missed or delayed dose is always the right call over improvisation.
If you are new to tirzepatide and researching how the full dosing schedule works, how Mounjaro dosing is structured walks through the titration pathway from starter dose to maintenance, which gives useful context for how each pen fits into the wider treatment plan. For a broader look at weight-loss treatment options available in the UK, our overview covers the current licensed medicines side by side.
Mounjaro is a prescription-only medicine. Any questions about your specific doses, pen technique, or what to do if a dose is missed should go to your prescriber. If you are considering starting treatment, start your free consultation with our GPhC-registered prescribers, who review every application personally.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.